AboutJayme Zage, PhD

As a senior member of Sg2’s service line thought leadership team, Jayme supports client needs across a broad range of service line initiatives, including structuring, strategic planning, workforce alignment, technology adoption and care delivery innovation. She is an esteemed thought leader in behavioral health and the neurosciences; while working on-site with clients, she leads behavioral health and neurosciences assessments that guide prioritization of program development and investment in these critical services. These assessments are developed in the context of emerging policy, payment, regulatory and local market dynamics and leverage national-level insights on leading practices that guide strategic investments.

During her 16-year tenure within Sg2’s intelligence delivery team, Jayme has developed the initial content for many service lines and topic areas, including behavioral health, neurosciences, women’s health, surgical services and post-acute care. Her experience in behavioral health services began more than a decade ago as she hosted Sg2’s first conference on the topic, and her ongoing work and experience in the field drove the launch of Sg2’s full behavioral health service line offering in 2017. She is a seasoned speaker who regularly appears in Sg2’s Executive Summit conference series and Sg2 webinars and has been invited to speak at national conferences on both neurosciences and behavioral health topics. She has also been a key note speaker for Medtronic’s Neuroscience Healthcare Summit, Neurosurgery Executives’ Resource Value and Education Society, American Academy of Neurology, the Congress of Neurosurgeons and the Association for Ambulatory Behavioral Healthcare.

Before joining Sg2, Jayme worked with Technomic International’s pharmaceutical group and Abbott Laboratories’ drug-coated stent program. These experiences extended her field of expertise to include drug development, marketing and regulatory issues.

As a part of her masters and doctoral work at Columbia University, Jayme studied and researched the molecular mechanism of disease. Her examination of basic cellular function can be applied to numerous diseases, including diabetes, Alzheimer disease, viral and bacterial infections, and cystic fibrosis.

Jayme remained at Columbia University as a National Institutes of Health–funded postdoctoral fellow to research the function of neuronal proteins—molecules implicated in numerous diseases. In her postdoctoral training at the University of Chicago, she examined the role of presenilin in Alzheimer disease. Jayme has a BS in chemistry from the Colorado School of Mines.

"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube